BSE · VANTABIO

Vanta Bioscience Limited

Sector: Healthcare · ISIN: INE695X01011

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,206

of 5,004 stocks

🏆 New peak

▲ 731W

Peak #4,206 · 01 Oct 2026

A microcap name in Healthcare, Vanta Bioscience Limited carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 73%, and is seeing revenue slip. Ownership as of Mar 2026.

Market Cap

16.09 Cr

P/E Ratio

150.80

P/B Ratio

—

ROE

—

ROCE

1.46%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Quarterly financials for this stock haven't been ingested yet — check back soon.

Shareholding pattern

Promoter

72.81%

Public

27.19%

PUBLIC BREAKDOWN

Individuals

24.58%

As of 31 Mar 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs